ACUTAAS CHEMICALS LTD
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications. It als… Read more
ACUTAAS CHEMICALS LTD (ACUTAAS) - Net Assets
Latest net assets as of September 2025: ₹14.39 Billion INR
Based on the latest financial reports, ACUTAAS CHEMICALS LTD (ACUTAAS) has net assets worth ₹14.39 Billion INR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹16.96 Billion) and total liabilities (₹2.57 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹14.39 Billion |
| % of Total Assets | 84.87% |
| Annual Growth Rate | 36.21% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 37.25 |
ACUTAAS CHEMICALS LTD - Net Assets Trend (2022–2025)
This chart illustrates how ACUTAAS CHEMICALS LTD's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ACUTAAS CHEMICALS LTD (2022–2025)
The table below shows the annual net assets of ACUTAAS CHEMICALS LTD from 2022 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | ₹13.20 Billion | +93.35% |
| 2024-03-31 | ₹6.83 Billion | +14.95% |
| 2023-03-31 | ₹5.94 Billion | +13.73% |
| 2022-03-31 | ₹5.22 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to ACUTAAS CHEMICALS LTD's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 123.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₹4.53 Billion | 34.62% |
| Common Stock | ₹409.35 Million | 3.13% |
| Other Comprehensive Income | ₹21.08 Million | 0.16% |
| Other Components | ₹8.13 Billion | 62.09% |
| Total Equity | ₹13.10 Billion | 100.00% |
ACUTAAS CHEMICALS LTD Competitors by Market Cap
The table below lists competitors of ACUTAAS CHEMICALS LTD ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Wildpack Beverage Inc
PINK:WLDPF
|
$259.25K |
|
Plastofil -L
TA:PPIL
|
$259.26K |
|
PVEX
BATS:PVEX
|
$259.51K |
|
General Shopping e Outlets do Brasil S.A.
SA:GSHP3
|
$259.78K |
|
MITSUI O.S.K.LINES
BE:MILA
|
$259.03K |
|
TERADATA
BE:3T4
|
$258.98K |
|
More Mutual Funds Management (2013) Ltd. - MORE SAL (4A) TA-90 IL
TA:MORE-S8
|
$258.97K |
|
GS YUASA - Dusseldorf Stock Exchang
DU:G9Y
|
$258.88K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ACUTAAS CHEMICALS LTD's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 6,739,974,000 to 13,096,287,000, a change of 6,356,313,000 (94.3%).
- Net income of 1,587,136,000 contributed positively to equity growth.
- Dividend payments of 122,783,000 reduced retained earnings.
- New share issuances of 4,993,889,000 increased equity.
- Other comprehensive income increased equity by 21,084,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹1.59 Billion | +12.12% |
| Dividends Paid | ₹122.78 Million | -0.94% |
| Share Issuances | ₹4.99 Billion | +38.13% |
| Other Comprehensive Income | ₹21.08 Million | +0.16% |
| Other Changes | ₹-123.01 Million | -0.94% |
| Total Change | ₹- | 94.31% |
Book Value vs Market Value Analysis
This analysis compares ACUTAAS CHEMICALS LTD's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 13.81x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 31.50x to 13.81x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-03-31 | ₹71.67 | ₹2257.80 | x |
| 2023-03-31 | ₹81.50 | ₹2257.80 | x |
| 2024-03-31 | ₹91.38 | ₹2257.80 | x |
| 2025-03-31 | ₹163.45 | ₹2257.80 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ACUTAAS CHEMICALS LTD utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.12%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 15.76%
- • Asset Turnover: 0.65x
- • Equity Multiplier: 1.18x
- Recent ROE (12.12%) is above the historical average (11.79%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | 13.78% | 13.83% | 0.79x | 1.26x | ₹197.19 Million |
| 2023 | 14.02% | 13.59% | 0.80x | 1.29x | ₹238.94 Million |
| 2024 | 7.23% | 6.79% | 0.65x | 1.63x | ₹-186.92 Million |
| 2025 | 12.12% | 15.76% | 0.65x | 1.18x | ₹277.51 Million |
Industry Comparison
This section compares ACUTAAS CHEMICALS LTD's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $2,197,575,447
- Average return on equity (ROE) among peers: 15.64%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ACUTAAS CHEMICALS LTD (ACUTAAS) | ₹14.39 Billion | 13.78% | 0.18x | $259.11K |
| Aarti Industries Limited (AARTIIND) | $8.75 Billion | 18.56% | 2.05x | $1.03 Billion |
| Aarti Surfactants Limited (AARTISURF) | $2.18 Billion | 9.78% | 0.94x | $15.41 Million |
| ABM International Limited (ABMINTLLTD) | $214.51 Million | 3.09% | 0.89x | $294.24K |
| Advanced Enzyme Technologies Limited (ADVENZYMES) | $984.09 Million | 34.30% | 2.55x | $95.57 Million |
| Agarwal Industrial Corporation Limited (AGARIND) | $739.40 Million | 9.29% | 0.98x | $26.97 Million |
| Alkali Metals Limited (ALKALI) | $513.80 Million | 2.54% | 0.73x | $1.91 Million |
| Alkyl Amines Chemicals Limited (ALKYLAMINE) | $3.79 Billion | 22.71% | 1.01x | $216.30 Million |
| Ami Organics Limited (AMIORG) | $107.73 Million | 26.58% | 2.59x | $704.27 Million |
| Anupam Rasayan India Limited (ANURAS) | $2.50 Billion | 13.94% | 1.53x | $319.86 Million |